Sunitinib malate and Toprol-xl drug interactions - a phase IV clinical study of FDA data
Summary:
Drug interactions are reported among people who take Sunitinib malate (sunitinib malate) and Toprol-xl (metoprolol succinate). Common drug interactions include cerebral ischaemia among females and renal failure acute among males.
The phase IV clinical study analyzes what interactions people have when they take Sunitinib malate and Toprol-xl. It is created by eHealthMe based on reports of 35 people who take the same drugs from the FDA, and is updated regularly.
What is Sunitinib malate?
Sunitinib malate has active ingredients of sunitinib malate. eHealthMe is studying from 9,160 Sunitinib malate users. Check the latest studies of Sunitinib malate.
What is Toprol-xl?
Toprol-xl has active ingredients of metoprolol succinate. It is often used in high blood pressure. eHealthMe is studying from 40,636 Toprol-xl users. Check the latest studies of Toprol-xl.
35 people who take Sunitinib malate and Toprol-xl together, and have interactions are studied.

What are the common drug interactions of Sunitinib Malate and Toprol-Xl, by gender? *:
female:
- Cerebral ischaemia (insufficient blood flow to the brain to meet metabolic demand)
- Hypokalaemia (low potassium)
- Left ventricular dysfunction
- Coronary artery occlusion (complete obstruction of blood flow in a coronary artery)
- Coronary artery stenosis (narrowing of coronary artery)
- Diarrhoea
- Ejection fraction decreased (systolic heart failure)
- Microangiopathic haemolytic anaemia (anaemia due to inability of bone marrow to compensate the premature destruction of red blood cells)
- Myocardial infarction (destruction of heart tissue resulting from obstruction of the blood supply to the heart muscle)
- Thrombocytopenia (decrease of platelets in blood)
male:
- Renal failure acute (rapid kidney dysfunction)
- Diarrhoea
- Intussusception
- Respiratory failure (inadequate gas exchange by the respiratory system)
- Thrombocytopenia (decrease of platelets in blood)
- Vomiting
- Abdominal discomfort
- Contusion (a type of hematoma of tissue in which capillaries)
- Nausea (feeling of having an urge to vomit)
- Cerebrovascular accident (sudden death of some brain cells due to lack of oxygen when the blood flow to the brain is impaired by blockage or rupture)
What are the common drug interactions of Sunitinib Malate and Toprol-Xl, by age (0-1 to 60+)? *:
0-1:
n/a
2-9:
n/a
10-19:
n/a
20-29:
n/a
30-39:
n/a
40-49:
- Hyperglycaemia (high blood sugar)
- Infection
50-59:
- Syncope (loss of consciousness with an inability to maintain postural tone)
- Dehydration (dryness resulting from the removal of water)
- Gastrointestinal necrosis (destruction of gastrointestinal organ)
- Hypokalaemia (low potassium)
- Hypotension (abnormally low blood pressure)
- Hypovolaemia (a decreased volume of circulating blood in the body)
- Intussusception
- Left ventricular dysfunction
- Renal failure acute (rapid kidney dysfunction)
- Respiratory failure (inadequate gas exchange by the respiratory system)
60+:
- Diarrhoea
- Thrombocytopenia (decrease of platelets in blood)
- Hypotension (abnormally low blood pressure)
- Localised oedema (fluid retention in a particular part of the body)
- Mucosal inflammation (infection of mucous membrane)
- Swollen tongue (swelling of tongue)
- Deep vein thrombosis (blood clot in a major vein that usually develops in the legs and/or pelvis)
- Enterocolitis (inflammation of the digestive tract, involving enteritis of the small intestine and colitis of the colon)
- Pulmonary embolism (blockage of the main artery of the lung)
- Body temperature decreased
What are the existing conditions these people have? *
- Renal Cell Carcinoma (a kidney cancer): 15 people, 42.86%
- Lung Cancer - Non-Small Cell (lung cancer): 6 people, 17.14%
- Insomnia (sleeplessness): 4 people, 11.43%
- Diabetes: 4 people, 11.43%
- Bladder Transitional Cell Carcinoma (types of bladder cancer): 4 people, 11.43%
- Ventricular Extrasystoles (premature cardiac contraction): 3 people, 8.57%
- Seasonal Allergy (allergic condition due to certain season): 3 people, 8.57%
- Prostate Cancer: 3 people, 8.57%
- Nausea (feeling of having an urge to vomit): 3 people, 8.57%
- Metastases To Bone (cancer spreads to bone): 3 people, 8.57%
* Approximation only. Some reports may have incomplete information.
Do you take Sunitinib malate and Toprol-xl?
- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously
Related studies:
Effectiveness of, side effects of, and alternative drugs to the 2 drugs:
- Sunitinib malate (9,160 reports)
- Toprol-xl (40,636 reports)
Browse all drug interactions of Sunitinib malate and Toprol-xl:
a b c d e f g h i j k l m n o p q r s t u v w x y zSub-studies by gender and age:
Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+
Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+
Browse all side effects of Sunitinib malate:
a b c d e f g h i j k l m n o p q r s t u v w x y zBrowse all side effects of Toprol-xl:
a b c d e f g h i j k l m n o p q r s t u v w x y zBrowse all interactions between Sunitinib malate and drugs from A to Z:
a b c d e f g h i j k l m n o p q r s t u v w x y zBrowse all interactions between Toprol-xl and drugs from A to Z:
a b c d e f g h i j k l m n o p q r s t u v w x y zHow the study uses the data?
The study uses data from the FDA. It is based on sunitinib malate and metoprolol succinate (the active ingredients of Sunitinib malate and Toprol-xl, respectively), and Sunitinib malate and Toprol-xl (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.
How to use the study?
DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.
Who is eHealthMe?
With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).
WARNING, DISCLAIMER, USE FOR PUBLICATION
WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.
DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.
If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.
Recent studies on eHealthMe:
- Could Colchicine cause C-Reactive Protein Decreased? - 19 seconds ago
- Could Glucagon cause Haemorrhoids? - 24 seconds ago
- Could Garamycin cause Thrombocytopenia? - 26 seconds ago
- Vicoprin vs. Indocin, side effect and effectiveness comparison - 35 seconds ago
- Could Lithium Carbonate cause Breast Cancer Aggravated? - 43 seconds ago
- Drug interactions of Neupogen and Avalide - 47 seconds ago
- Could Bactrim Ds cause Bone Marrow Depression? - 53 seconds ago
- Peptic Ulcer Aggravated and Joint Range Of Motion Decreased - a minute ago
- Drug interactions of Vitamin B12 and Janumet - a minute ago
- Drug interactions of Lutein and Remicade - a minute ago